EGRX
Eagle Pharmaceuticals Inc
Price:  
2.14 
USD
Volume:  
4,664,101.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EGRX Relative Valuation

6743.3%
Upside

As of 2024-12-05, the Relative Valuation of Eagle Pharmaceuticals Inc (EGRX) is 146.45 USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.14 USD, the upside of Eagle Pharmaceuticals Inc based on Relative Valuation is 6743.3%.

The range of the Relative Valuation is 70.15 - 211.92 USD.

Range Selected
Trailing P/E multiples 25.0x - 37.5x 35.9x
Forward P/E multiples 25.2x - 36.5x 33.1x
Fair Price 70.15 - 211.92 146.45
Upside 3178.0% - 9803.0% 6743.3%
2.14 USD
Stock Price
146.45 USD
Fair Price

EGRX Relative Valuation - Historical P/E Data

Date P/E
2024-11-29 0.25
2024-11-27 0.25
2024-11-26 0.34
2024-11-25 0.30
2024-11-22 0.34
2024-11-21 0.32
2024-11-20 0.23
2024-11-19 0.23
2024-11-18 0.32
2024-11-15 0.23
2024-11-14 0.25
2024-11-13 0.27
2024-11-12 0.32
2024-11-11 0.30
2024-11-08 0.30
2024-11-07 0.30
2024-11-06 0.28
2024-11-05 0.28
2024-11-04 0.18
2024-11-01 0.20
2024-10-31 0.21
2024-10-30 0.18
2024-10-29 0.14
2024-10-28 0.12
2024-10-25 0.21
2024-10-24 0.23
2024-10-23 0.23
2024-10-22 0.25
2024-10-21 0.25
2024-10-18 0.32
2024-10-17 0.23
2024-10-16 0.28
2024-10-15 0.21
2024-10-14 0.21
2024-10-11 0.31
2024-10-10 0.21
2024-10-09 0.33
2024-10-08 0.20
2024-10-07 0.23
2024-10-04 0.32
2024-10-03 0.71
2024-10-02 0.76
2024-10-01 1.27
2024-09-30 1.33
2024-09-27 1.41
2024-09-26 1.45
2024-09-25 1.38
2024-09-24 1.39
2024-09-23 1.39
2024-09-20 1.41